Based on the new t-ROC (Figs. S1G–S1I), calibration curve (Figs. S1J–S1L), and DCA (Figs. S1M–S1O) analyses, we found that the prediction accuracy and net benefits of the model were still stable regardless of whether GBM was characterized by IDH1 mutation. Here, IDH1 is linked to glioblastoma.